Company news
TheraCryf PLC news in 2021
TheraCryf PLC's news releases, calls and decks from 2021, newest first.
Grant of Options
December 8, 2021
Publication of data on SFX-01 in glioblastoma
November 10, 2021
Publication of data in glioblastoma cells
September 20, 2021
Glioma Orphan Drug designation granted by FDA
September 2, 2021
Result of AGM and Business Update
July 13, 2021
Interim Safety and Futility Analysis - STAR trial
July 9, 2021
Posting of Annual Report and Notice of AGM
June 18, 2021
Progress with Glioma/Glioblastoma programme
June 14, 2021
Appointment of Chief Medical Officer
April 26, 2021
Publication on sulforaphane in COVID-19
April 7, 2021
Appointment of Chief Business Officer
March 22, 2021
Update on Data Safety Review - STAR COVID-19 trial
March 11, 2021
Director dealing
March 5, 2021
Result of General Meeting & Total Voting Rights
March 3, 2021
Update on patient recruitment
February 17, 2021
Posting of Circular & Notice of GM
February 12, 2021
Placing and Open Offer to raise up to £11 million
February 2, 2021
Preclinical data on a new therapeutic target
January 22, 2021
Positive pre-clinical data for lead asset SFX-01
January 21, 2021
Patient recruitment update in STAR-COVID 19 trial
January 19, 2021
Decks in 2021
- Evgen Pharma — Shareholder Meeting (July 2021)
Shareholder meeting · 13 slides · Jul 13, 2021